Latest news with #IgniteData
Yahoo
01-04-2025
- Health
- Yahoo
IgniteData to deploy EHR-to-EDC automation tool in Phase III trial at MSK
IgniteData has announced a partnership with AstraZeneca and Memorial Sloan Kettering Cancer Center (MSK) for launching the Archer tool for automation of electronic health record (EHR)-to-electronic data capture (EDC) in a Phase III trial at MSK. This initiative comes after a pilot programme, and it showcases the tool's ability to streamline trials by enhancing accuracy and speed. By the secure transfer of data from hospital EHRs directly to sponsor EDCs, the Archer platform removes the necessity for manually entering the data. This automation allows data to be gathered more swiftly and with minimal errors, enabling researchers to dedicate extra time to progressing clinical science while upholding subject privacy and data integrity. MSK Clinical Research Information Technology senior director Joe Lengfellner said: 'The IgniteData Archer platform continues to improve the speed and quality of our data collection across clinical trials. 'The implementation of Archer in this AstraZeneca-sponsored Phase III study demonstrates the growing industry-academia alignment on the future of trial data management. This convergence will accelerate trial execution and improve data quality across the clinical research ecosystem.' Archer serves as a Virtual Research Assistant. For researchers, the platform is found to be a 'simple interface', and its regulatory-grade mapping engine manages complex data integrations. IgniteData chief operating officer Richard Yeatman said: 'Our EHR-to-EDC automation technology is revolutionising how clinical trials are conducted. 'By reducing manual processes and ensuring data quality, we're empowering research teams to deliver life-saving treatments more efficiently. This deployment is another step toward transforming the clinical trial landscape.' IgniteData is focused on expanding its EHR-to-EDC automation across international research sites, aiming to enhance trial innovation. Every deployment of the platform is intended to provide insights that refine the technology, with the goal of delivering precise clinical trial outcomes. "IgniteData to deploy EHR-to-EDC automation tool in Phase III trial at MSK" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Associated Press
17-03-2025
- Business
- Associated Press
IgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals
CAMBRIDGE, United Kingdom, March 17, 2025 /PRNewswire/ -- IgniteData has announced a collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) and Cambridge University Hospitals NHS Foundation Trust (CUH) to launch its Archer tool for clinical data integration in an ongoing Phase 3 study sponsored by AstraZeneca. This collaboration marks a significant milestone in IgniteData's aim of transforming clinical trials through automation and digital innovation. IgniteData's Archer tool is a technology platform that upholds the highest standards of data security and automates the data transfer process between hospital Electronic Health Records (EHRs) and sponsor Electronic Data Capture (EDCs), allowing researchers to focus more of their time on clinical research and less time on data entry. With its system-agnostic design, Archer integrates effortlessly with leading EHRs and EDCs to map a multitude of study variables and transfer several hundred data points per patient, resulting in significant time savings while ensuring the highest levels of data integrity and maintaining patient data privacy. The collaboration between Cambridge University Hospitals, AstraZeneca, and IgniteData began in 2021, with AstraZeneca playing a key role in developing the Archer platform. After successful pilot studies at University College London Hospitals (UCLH) and Memorial Sloan Kettering Cancer Center (MSK), Archer is now being deployed in this pivotal study at Cambridge. All participating patients provided prior approval for the integration and use of their clinical data in the study. This collaboration underscores the commitment of both Cambridge University Hospitals and AstraZeneca to advancing clinical research through innovative technology. Dr. Wai Keong Wong, Clinical Director of Digital Transformation at CUH, expressed enthusiasm for the project, stating, 'The integration of Archer into our EHR system represents a significant leap forward in how we conduct clinical trials. The automation of data capture not only enhances efficiency but also ensures the highest standards of data integrity, which is crucial for the success of our research and, ultimately, for patient outcomes.' Richard Yeatman, COO of IgniteData, added, 'Our partnership with Cambridge University Hospitals and AstraZeneca is a testament to the power of collaboration in advancing clinical research. With Archer, we are laying the groundwork for a new era of digital innovation in clinical trials, one where data is transferred seamlessly, securely, and efficiently.' Looking Ahead The data and insights gained from this live integration will inform future deployments of Archer across other NHS and European hospitals. This marks just the beginning of a broader initiative to scale this technology globally with approved sponsors, transforming the way clinical trials are conducted and accelerating the delivery of life-saving treatments to patients. For more information about Archer and its role in modern clinical trials, visit IgniteData's website. About IgniteData IgniteData is the company shaping the future of clinical trials. Through its innovative digihealth platform, Archer, it is enhancing interoperability between Electronic Health Records (EHR) and key research applications such as Electronic Data Capture (EDC). IgniteData is transforming the future of clinical trials through its cloud-based Virtual Research Assistant, Archer. A system-agnostic solution, Archer brings modern interoperability between EHR and key research systems, such as EDC, to provide seamless, secure transfer of clinically- validated data for clinical trials.
